{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:45:33Z","timestamp":1791477933231,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"am","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jiac.2023.08.010","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T03:51:05Z","timestamp":1692417065000},"page":"1126-1131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognoses of patients undergoing hemodialysis administered 23-valent pneumococcal polysaccharide versus 13-valent pneumococcal protein conjugate vaccines"],"prefix":"10.1016","volume":"29","author":[{"given":"Kosei","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0003-8645","authenticated-orcid":false,"given":"Mineaki","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0696-5386","authenticated-orcid":false,"given":"Takahiro","family":"Takazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiroh","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Funakoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2023.08.010_bib1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/ndt\/gfw249","article-title":"Mortality trends among Japanese dialysis patients, 1988-2013: a joinpoint regression analysis","volume":"31","author":"Wakasugi","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jiac.2023.08.010_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ackd.2006.04.004","article-title":"Infectious complications in chronic kidney disease","volume":"13","author":"Naqvi","year":"2006","journal-title":"Adv Chron Kidney Dis"},{"key":"10.1016\/j.jiac.2023.08.010_bib3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ndt\/gfm474","article-title":"Pneumonia in incident dialysis patients - the United States renal data system","volume":"23","author":"Guo","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jiac.2023.08.010_bib4","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"2013","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jiac.2023.08.010_bib5","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.vaccine.2019.11.012","article-title":"Clinical effectiveness of 13Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: the EPIVAC cohort study","volume":"38","author":"Vila-Corcoles","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2023.08.010_bib6","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.vaccine.2013.04.084","article-title":"Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2023.08.010_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/IJNRD.S231142","article-title":"Current knowledge of vaccinations in chronic kidney disease patients","volume":"13","author":"Haddiya","year":"2020","journal-title":"Int J Nephrol Renovascular Dis"},{"key":"10.1016\/j.jiac.2023.08.010_bib8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.15585\/mmwr.mm6846a5","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 Years: updated recommendations of the advisory committee on immunization practices","volume":"68","author":"Matanock","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jiac.2023.08.010_bib9","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1016\/j.vaccine.2019.08.088","article-title":"23-Valent pneumococcal polysaccharide vaccine improves survival in dialysis patients by preventing cardiac events","volume":"37","author":"Ihara","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2023.08.010_bib10","first-page":"PA612","article-title":"No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure","volume":"48","author":"Hsieh","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2023.08.010_bib11","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1016\/j.vaccine.2020.09.080","article-title":"Effectiveness and safety of pneumococcal vaccines used alone or combined with influenza vaccination in dialysis patients: a systematic review and meta-analysis","volume":"38","author":"Mo","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2023.08.010_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s41100-022-00397-5","article-title":"Low humoral immune response to the BNT162b2 vaccine against COVID-19 in nursing home residents undergoing hemodialysis: a case\u2013control observational study","volume":"8","author":"Kitamura","year":"2022","journal-title":"Ren Replace Ther"},{"key":"10.1016\/j.jiac.2023.08.010_bib13","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jiac.2023.08.010_bib14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s10156-011-0228-z","article-title":"Clinical and microbiological evaluation of hemodialysis-associated pneumonia (HDAP): should HDAP be included in healthcare-associated pneumonia?","volume":"17","author":"Kawasaki","year":"2011","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2023.08.010_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.resinv.2012.11.001","article-title":"Clinical practice guidelines for nursing- and healthcare-associated pneumonia (NHCAP) [Complete translation]","volume":"51","author":"Kohno","year":"2013","journal-title":"Respir Investig"},{"key":"10.1016\/j.jiac.2023.08.010_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ehjqcco\/qcaa030","article-title":"Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis","volume":"7","author":"Marques Antunes","year":"2021","journal-title":"Eur Hear Journal Qual Care Clin Outcomes"},{"key":"10.1016\/j.jiac.2023.08.010_bib17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","article-title":"Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL","volume":"9","author":"Binder","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jiac.2023.08.010_bib18","article-title":"Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis","volume":"2","author":"Ren","year":"2015","journal-title":"Open Hear"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23001964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23001964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:06:44Z","timestamp":1761160004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X23001964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1341321X23001964"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2023.08.010","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognoses of patients undergoing hemodialysis administered 23-valent pneumococcal polysaccharide versus 13-valent pneumococcal protein conjugate vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2023.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}